Parameter | Before PTX | Baseline | Course | 9 months after treatment | Reference | ||||
---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |||||
WBC,10^9/L | 7.18 | 6.2 | 6.03 | 5.14 | 5.56 | 5.64 | 5.44 | 4.7 | 3.5–9.5 |
RBC,10^12/L | 2.41 | 3.50 | 3.84 | 4.23 | 4.46 | 4.44 | 4.51 | 4.75 | 4.3–5.8 |
Hb, g/L | 66 | 88 | 107 | 110 | 111 | 107 | 111 | 120 | 130–175 |
PLT,10^9/L | 316 | 184 | 181 | 220 | 172 | 163 | 163 | 149 | 125–350 |
NEUT%, T% | 0.73 | 0.730 | 0.656 | 0.428 | 0.539 | 0.581 | 0.594 | 0.667 | 0.4–0.75 |
Alb, g/L | 34.6 | 24.7 | 30.0 | 30.2 | 31.1 | 29.4 | 27.9 | 31.6 | 40–55 |
ALP, U/L | 453.6 | 252.2 | 379.5 | 371.1 | 328.3 | 276.8 | 232.5 | 149 | 45–125 |
Ca, mmo/L | 2.18 | 1.52 | 1.87 | 1.81 | 1.60 | 1.33 | 1.53 | 1.72 | 2.11–2.52 |
P, mmol/L | 2.77 | 1.76 | 1.53 | 1.45 | 1.59 | 1.79 | 1.75 | 2.33 | 0.85–1.51 |
PTH, pg/ml | 200 | 141.1 | - | 198.9 | 212.5 | 201.9 | 253.1 | 131 | 12–88 |